BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Hastings Center for Bioethics - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Hastings Center for Bioethics
X-ORIGINAL-URL:https://www.thehastingscenter.org
X-WR-CALDESC:Events for The Hastings Center for Bioethics
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220929T140000
DTEND;TZID=America/New_York:20220929T150000
DTSTAMP:20260427T121056
CREATED:20220823T155746Z
LAST-MODIFIED:20220921T144841Z
UID:54614-1664460000-1664463600@www.thehastingscenter.org
SUMMARY:Ethical & Regulatory Considerations in Xenotransplantation Clinical Trials: Patient Selection\, Equity in Access\, & Wait Listing
DESCRIPTION:The webinar aims to provide participants with the ethical\, regulatory\, and psychosocial context to address the following questions: \n\n\n\n– What strategies should be used to minimize clinical trial investigators’ conflict of interest in recruiting patients into xenotransplant clinical trials? \n\n\n\n– How should potential participants be notified about the option of participating in a xenotransplant clinic trial? \n\n\n\n– What are appropriate patient-provided reasons for participating in a xenotransplant clinical trial? \n\n\n\n– What constitutes equitable access to participating in xenotransplantation clinical trials? How can the transplant community ensure equitable access to xenotransplantation clinical trials? \n\n\n\n– What kinds of novel psychosocial experiences will pig xenotransplant recipients encounter post-transplant? What are the optimal ways for the transplant team\, particularly\, transplant social workers and psychologists\, to counsel recipients on their experiences? \n\n\n\n– Should xenotransplant recipients of a failed xenotransplant graft receive priority for a human deceased donor organ? Is there any concern for zoonotic infections with repeat immunosuppression induction? Should any extra priority be given because they contributed to the advancement of scientific knowledge? \n\n\n\nSponsored by the American Society of Transplantation Psychosocial and Ethics Community of Practice. Speakers: Andrew Adams\, MD\, PhD (University of Minnesota)\, Henry Silverman\, MD\, PhD (University of Maryland)\, Brendan Parent\, JD (New York University)\, Moderator: Karen J. Maschke\, PhD (The Hastings Center).
URL:https://www.thehastingscenter.org/hastings-center-event/ethical-and-regulatory-considerations-in-xenotransplantation-clinical-trials-patient-selection-equity-in-access-and-wait-listing/
LOCATION:Online
CATEGORIES:Virtual Event
ATTACH;FMTTYPE=image/jpeg:https://www.thehastingscenter.org/wp-content/uploads/Karen-Maschke.jpg
END:VEVENT
END:VCALENDAR